Instruction Source: D68.312
Antiphospholipid antibody with hemorrhagic disorder
Excludes 1 (Mutually Exclusive)
- antiphospholipid antibody, finding without diagnosis (R76.0)
- lupus anticoagulant (LAC) finding without diagnosis (R76.0)
- systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (R76.0)
Excludes 2 (Not Included Here)
- antiphospholipid antibody syndrome (D68.61)
- antiphospholipid antibody with hypercoagulable state (D68.61)
- lupus anticoagulant (LAC) with hypercoagulable state (D68.62)
- systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (D68.62)
Instruction Source: D68.31
Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
Instruction Source: D68.3
Hemorrhagic disorder due to circulating anticoagulants
Instruction Source: D68
Other coagulation defects
Excludes 1 (Mutually Exclusive)
- abnormal coagulation profile NOS (R79.1)
Excludes 2 (Not Included Here)
- coagulation defects complicating abortion or ectopic or molar pregnancy (O00-O07, O08.1)
- coagulation defects complicating pregnancy, childbirth and the puerperium (O45.0, O46.0, O67.0, O72.3)
Instruction Source: D65-D69
Coagulation defects, purpura and other hemorrhagic conditions (D65-D69)
Instruction Source: D50-D89
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
Excludes 2 (Not Included Here)
- autoimmune disease (systemic) NOS (M35.9)
- certain conditions originating in the perinatal period (P00-P96)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- human immunodeficiency virus [HIV] disease (B20)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)